Viking Therapeutics (NASDAQ: VKTX)
$41.40
(-3.0%)
-$1.28
Price as of December 27, 2024, 1:45 p.m. ET
Viking Therapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Viking Therapeutics Company Info
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.
News & Analysis
The Fool has written over 200 articles on Viking Therapeutics.
Featured Article
Down 18% in 1 Day, Is Viking Therapeutics Stock in Trouble Due to Merck?
Alex Carchidi | Dec 21, 2024
Featured Article
Why Viking Therapeutics Tumbled by More Than 10% This Week
Eric Volkman | Dec 20, 2024
Prediction: These Could Be the Best-Performing Pharma and Biotech Stocks Through 2030
Adria Cimino | Dec 16, 2024
2 Soaring Stocks That Could Climb 68% to 166% Higher in 2025, According to Wall Street
Cory Renauer | Dec 15, 2024
Warning: This Skyrocketing Stock Has a Hidden Risk
Adria Cimino | Dec 10, 2024
After Crashing 27% in the Past Month, Is Viking Therapeutics Stock a Bargain Buy Right Now?
David Jagielski | Dec 3, 2024
Here's Yet Another Reason to Buy Viking Therapeutics Stock Like There's No Tomorrow
Alex Carchidi | Nov 26, 2024
Billionaire Ken Griffin Invested $93 Million of Citadel's Portfolio in a Stock That Could Rocket 105% Higher, According to a Wall Street Analyst
Cory Renauer | Nov 25, 2024
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.